Evaluation of recombinant serine-rich 45-kDa antigen (ML0411) for detection of antibodies in leprosy patients

Scandinavian Journal of Immunology

Volumn 64, Issue 4, 2006, Pages 450-455

  Parkash, O ^a   Kumar, A ^b   Nigam, A ^c   Franken, K L M C ^d   Ottenhoff, T H M ^d  

^a NATIONAL JALMA INSTITUTE FOR LEPROSY AND OTHER MYCOBACTERIAL DISEASES   (India)

^b BUNDELKHAND UNIVERSITY   (India)

^c DR B R AMBEDKAR UNIVERSITY   (India)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIGEN; BACTERIUM ANTIBODY; DIAGNOSTIC AGENT; ML 0411; PHENOLIC GLYCOLIPID I; PROTEIN ANTIBODY; RECOMBINANT ANTIGEN; SERINE; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; BACTERIUM DETECTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; INDIA; LEPROSY; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; MULTIBACILLARY LEPROSY; MYCOBACTERIUM LEPRAE; PAUCIBACILLARY LEPROSY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SKIN DISEASE; TUBERCULOSIS;

ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; B-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOLIPIDS; HUMANS; LEPROSY; LYMPHOCYTE ACTIVATION; MOLECULAR WEIGHT; MYCOBACTERIUM LEPRAE; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; SERINE;

EID: 33748788514     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2006.01824.x     Document Type: Article

References (27)

1. Ridley DS, Jopling WH. Classification of leprosy according to immunity: a five-group system. Int J Lepr Other Mycobact Dis 1966;34:255-73.
2. Bach MA, Wallach D, Flageul B, Hoffenbach A, Cottenot F. Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy. Int J Lepr Other Mycobact Dis 1986;54:256-67.
3. Klatser PR. Serology of leprosy. Trop Geog Med 1994;46:115-8.
4. Parkash O. Progress towards detection of Mycobactertum leprae infection, employing 35 kDa antigen: an update. Lepr Rev 2002;72:9-19.
5. Oskam L, Slim E, Buhrer-Sekula S. Serology in leprosy research and control: recent developments, strengths, limitations and prospects: a state of the art overview. Lepr Rev 2003;74:196-205.
6. Thole JE, Wieles B, Clark-Curtiss JE, Ottenhoff TH, Rinke de Wit TF. Immunological and functional characterization of Mycobacterium leprae protein antigens: an overview. Mol Microb 1995;18:791-800.
7. Spencer JS, Dockrell HM, Kim HJ et al. Identification of specific proteins and peptides in Mycobacterium leprae suitable for the selective diagnosis of leprosy. J Immunol 2005;175:7930-8.
8. Geluk A, Klein MR, Franken K et al. A postgenomic approach to identify novel antigens of Mycobacterium leprae for improved immunodiagnosis of M. leprae infection. Infect Immun 2005;73:5636-44.
9. Araoz R, Honore N, Cho S et al. Antigen discovery: a postgenomic approach to leprosy diagnosis. Infect Imuun 2006;74:175-82.
10. Vega-Lopez F, Brooks LA, Dockrell HM et al. Sequence and immunological characterization of a serine-rich antigen from Mycobacterium leprae. Infect Immun 1993;61:2145-53.
11. Cole ST, Eiglmeier K, Parkhill J et al. Massive gene decay in the leprosy bacillus. Nature 2001;409:1007-11.
12. Rinke de Wit TF, Clark-Curtiss JE, Abebe F et al. A Mycobacterium leprae-specific gene encoding an immunologically recognized 45 kDa protein. Mol Microb 1993;10:829-38.
13. WHO. Expert committee on leprosy. World Health Organ Tech Rep Ser 1998;874:1-43.
14. Macfarlane A, Mondragon-Gonzalez R, Vega-Lopez F et al. Presence of human T-cell responses to the Mycobacterium leprae 45-kilodalton antigen reflects infection with or exposure to M. leprae. Clin Dia Lab Immunol 2001;8:604-11.
15. Roche PW, Britton WJ, Failbus SS, Williams D, Pradhan HM, Theuvenet WJ. Operational value of serological response in multi-bacillay leprosy patients and bacteriological correlates of antibody response. Int J Lepr Other Mycobact Dis 1990;58:480-90.
16. Buhrer-Sekula S, Smits HL, Gussenhoven GC et al. Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy. J Clin Microb 2003;41:1991-5.
17. Roche PW, Britton WJ, Failbus SS, Neupane KD, Theuvenet WJ. Serological monitoring of the response to chemotherapy in leprosy patients. Int J Lepr Other Mycobact Dis 1993;61:35-43.
18. Wu Q, Yin Y, Zhang L et al. A study on a possibility of predicting early relapse in leprosy using a ND-O-BSA based ELISA. Int J Lepr Other Mycobact Dis 2002;70:1-8.
19. Chujor CS, Bernheimer H, Levis WR, Schwerer B. Serum IgA1 and IgM antibodies against Mycobacterium leprae-derived phenolic glycolipid-I: a comparative study in leprosy patients and their contacts. Int J Lepr Other Mycobact Dis 1991;59:441-9.
20. WHO. Expert committee on leprosy. World Health Organ Tech Rep Ser 1988;768:1-51.
21. Cole ST, Brosch R, Parkhill J et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998;393:537-44.
22. Le Moigne V, Robreau G, Borot C, Guesdon JL, Mahana W. Expression, immunochemical characterization and localization of the Mycobacterium tuberculosis protein p27. Tuberculosis 2005;85:213-9.
23. Brahmbhatt S, Hussain R, Zafar S et al. Human T cell responses to peptides of the Mycobacterium leprae 45-kD serine-rich antigen. Clin Exp Immunol 2002;128:140-8.
24. Geluk A, van Meijgaarden KE, Franken KL et al. Identification and characterization of the ESAT-6 homologue of Mycobacterium leprae and T-cell cross-reactivity with Mycobacterium tuberculosis. Infect Immun 2002;70:2544-8.
25. Geluk A, van Meijgaarden KE, Franken KLMC et al. Immunological Crossreactivity of the Mycobacterium leprae CFP-10 with its homologue in Mycobacterium tuberculosis. Scand J Immunol 2004;59:66-70.
26. Spencer JS, Marques MM, Lima MCBS et al. Antigenic specificity of the Mycobacterium leprae homologue of ESAT-6. Infect Immun 2002;70:1010-3.
27. Spencer JS, Kim HJ, Marques MM et al. Comparative analysis of B and T-cell epitopes of Mycobacterium leprae and Mycobacterium tuberculosis culture filtrate protein-10. Infect Immun 2004;72:3161-70.